December 7, 2023 – In August 2023, the pCPA engaged with clinicians, patient groups and industry to present and hear feedback on a set of principles and conditions for a pCPA Temporary Access Process (pTAP).
October 26, 2023 – The pCPA Board of Directors is thrilled to release the organization’s inaugural report, a report that is a testament to the transformative nature of this past year.
The pan-Canadian Pharmaceutical Alliance Corporation (pCPA) Annual General Meeting
To be held at 2125 Victoria Avenue, Regina, SK. S4P 0S3 on October 25, 2023 at 5 p.m. CST
Notice is hereby given that the first Annual General Meeting of the members of the pan-Canadian Pharmaceutical Alliance Corporation (pCPA) will take place on Wednesday, October 25, 2023 at 5 p.m. CST. Members may participate in person or virtually.
The new three-year pricing initiative for generic drugs will come into effect on October 1, 2023.
The agreement between the pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) builds upon the successes achieved to date with the pan-Canadian Generic Tiered Pricing Framework (TPF) and the pan-Canadian molecules.
The pan-Canadian Pharmaceutical Alliance’s (pCPA) Board of Directors is excited to announce that Douglas Clark will become the first CEO of the newly incorporated organization, effective September 11, 2023
The pCPA is accepting feedback regarding the development of a set of principles and conditions that will inform the negotiation process and potential product listing agreements for any drug products that follow the CADTH time-limited recommendation pathway.
The pan-Canadian Pharmaceutical Alliance is continuing the transition to a stand-alone organization including recruiting key leaders and ensuring all necessary operational supports are in place.
Working with the global executive search firm Odgers Berndtson, the pan-Canadian Pharmaceutical Alliance (pCPA) is recruiting a chief executive officer as it continues its transition to a stand-alone organization. The new CEO is expected to be in place this spring. Read the full update.